ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135077 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135077; 2) Community: the network communities that were significantly associated with the response to NSC 135077; 3) Molecule: the relationships between components within communities and NSC 135077; 4) MDR: the compounds that were significantly associated with the NSC 135077.

NSC Compound Enrichment Correlation
NSC 618296 Null 0.0171490505199913 0.26246727
NSC 624166 Null 0.0171490505199913 0.29315668
NSC 628121 Null 0.0171490505199913 0.22235147
NSC 628562 4H-1,3,2-Benzodioxastannin-4-one, 7-amino-2,2-diphenyl- 0.0171490505199913 0.28609674
NSC 629749 .beta.-Lapachone 0.0171490505199913 0.24667032
NSC 633497 Null 0.0171490505199913 0.1741981
NSC 635979 Null 0.0171490505199913 0.19595757
NSC 636092 Pyridine-3,5-dicarboxamide, 1,4-dihydro-2,6-dimethyl- 4-[4-(dimethylamino)phenyl]-N,N'-diphenyl- 0.0171490505199913 0.09760531
NSC 643845 Null 0.0171490505199913 0.24159923
NSC 648365 Insulin-Methotrexate conjugate 0.0171490505199913 0.33620244
Total:126  Current:55    [First] [Prev] [Next] [Last]